Kitoxan®
home > Kitoxan®
Kitoxan® by Latoxan
The first natural library of venom fractions for Drug Discovery and High Throughput Screening (HTS).
Kitoxan Kitoxan V01 Kitoxan V02 Kitoxan V03 Kitoxan V04
<< Back to Kitoxan V04

Search : `Walterinnesia aegyptia` - PubMed Results: 40
  1. Effective Soybean Oil Degumming by Immobilized Phospholipases A(2) from Walterinnesia aegyptia Venom.
    Bacha AB, Alonazi M
    ACS Omega 2024 May 14;9(19):21322-21332 PMID:38764629 PubMed

  2. Venom of the desert black snake Walterinnesia aegyptia enhances anti-tumor immunity via its beneficial modulatory effects on pro- and anti-tumorigenic inflammatory mediators in cultured colon cancer cells.
    Daghestani MH, Ambreen K, Hakami HH, Omair MA, Saleem AM, Aleisa NA, AlNeghery LM, Amin MH, Alobaid HM, Omair MA, Hassen LM
    Toxicol Res (Camb) 2021 Dec;10(6):1116-1128 PMID:34956615 PubMed

  3. Combined Molecular and Elemental Mass Spectrometry Approaches for Absolute Quantification of Proteomes: Application to the Venomics Characterization of the Two Species of Desert Black Cobras, Walterinnesia aegyptia and Walterinnesia morgani.
    Calvete JJ, Pla D, Els J, Carranza S, Damm M, Hempel BF, John EBO, Petras D, Heiss P, Nalbantsoy A, Göçmen B, Süssmuth RD, Calderón-Celis F, Nosti AJ, Encinar JR
    J Proteome Res 2021 Nov 5;20(11):5064-5078 PMID:34606723 PubMed - indexed for MEDLINE

  4. Identification, Characterization and Synthesis of Walterospermin, a Sperm Motility Activator from the Egyptian Black Snake Walterinnesia aegyptia Venom.
    Abd El-Aziz TM, Jaquillard L, Bourgoin-Voillard S, Martinez G, Triquigneaux M, Zoukimian C, Combemale S, Hograindleur JP, Al Khoury S, Escoffier J, Michelland S, Bulet P, Beroud R, Seve M, Arnoult C, De Waard M
    Int J Mol Sci 2020 Oct 21;21(20) PMID:33096770 PubMed - indexed for MEDLINE

  5. A novel bactericidal homodimeric PLA(2) group-I from Walterinnesia aegyptia venom.
    Ben Bacha A, Alonazi MA, Elshikh MS, Karray A
    Int J Biol Macromol 2018 Oct 1;117:1140-1146 PMID:29885399 PubMed - indexed for MEDLINE

  6. Actiflagelin, a new sperm activator isolated from Walterinnesia aegyptia venom using phenotypic screening.
    Abd El-Aziz TM, Al Khoury S, Jaquillard L, Triquigneaux M, Martinez G, Bourgoin-Voillard S, Sève M, Arnoult C, Beroud R, De Waard M
    J Venom Anim Toxins Incl Trop Dis 2018;24:2 PMID:29410678 PubMed

  7. Assessment of the Antimicrobial Activity of Few Saudi Arabian Snake Venoms.
    Al-Asmari AK, Abbasmanthiri R, Abdo Osman NM, Siddiqui Y, Al-Bannah FA, Al-Rawi AM, Al-Asmari SA
    Open Microbiol J 2015;9:18-25 PMID:26668657 PubMed

  8. Biochemical characterization of a factor X activator protein purified from Walterinnesia aegyptia venom.
    Khan SU, Al-Saleh SS
    Blood Coagul Fibrinolysis 2015 Oct;26(7):772-7 PMID:26407136 PubMed - indexed for MEDLINE

  9. Fractionation and proteomic analysis of the Walterinnesia aegyptia snake venom using OFFGEL and MALDI-TOF-MS techniques.
    Abd El Aziz TM, Bourgoin-Voillard S, Combemale S, Beroud R, Fadl M, Seve M, De Waard M
    Electrophoresis 2015 Oct;36(20):2594-605 PMID:26178575 PubMed - indexed for MEDLINE

  10. The effect of Walterinnesia aegyptia venom proteins on TCA cycle activity and mitochondrial NAD(+)-redox state in cultured human fibroblasts.
    Ghneim HK, Al-Sheikh YA, Aboul-Soud MA
    Biomed Res Int 2015;2015:738147 PMID:25705684 PubMed - indexed for MEDLINE

  11. Increased susceptibility to apoptosis and growth arrest of human breast cancer cells treated by a snake venom-loaded silica nanoparticles.
    Badr G, Sayed D, Maximous D, Mohamed AO, Gul M
    Cell Physiol Biochem 2014;34(5):1640-51 PMID:25401286 PubMed - indexed for MEDLINE

  12. Identification and phylogeny of Arabian snakes: Comparison of venom chromatographic profiles versus 16S rRNA gene sequences.
    Al Asmari A, Manthiri RA, Khan HA
    Saudi J Biol Sci 2014 Nov;21(5):436-41 PMID:25313278 PubMed

  13. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction.
    Al-Sadoon MK, Rabah DM, Badr G
    Cell Immunol 2013 Jul-Aug;284(1-2):129-38 PMID:23973876 PubMed - indexed for MEDLINE

  14. Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models.
    Badr G, Al-Sadoon MK, Rabah DM
    Free Radic Biol Med 2013 Dec;65:175-189 PMID:23811005 PubMed - indexed for MEDLINE

  15. Silica nanoparticles sensitize human multiple myeloma cells to snake (Walterinnesia aegyptia) venom-induced apoptosis and growth arrest.
    Sayed D, Al-Sadoon MK, Badr G
    Oxid Med Cell Longev 2012;2012:386286 PMID:23304253 PubMed - indexed for MEDLINE

  16. Cellular and molecular mechanisms underlie the anti-tumor activities exerted by Walterinnesia aegyptia venom combined with silica nanoparticles against multiple myeloma cancer cell types.
    Badr G, Al-Sadoon MK, Abdel-Maksoud MA, Rabah DM, El-Toni AM
    PLoS One 2012;7(12):e51661 PMID:23251606 PubMed - indexed for MEDLINE

  17. Snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles induce apoptosis and growth arrest in human prostate cancer cells.
    Badr G, Al-Sadoon MK, Rabah DM, Sayed D
    Apoptosis 2013 Mar;18(3):300-14 PMID:23238991 PubMed - indexed for MEDLINE

  18. Identification and discrimination of snake venoms from Egyptian elapids.
    Ibrahim NM, El-Kady EM, Katamesh RA, El-Borei IH, Wahby AF
    Toxicon 2013 Mar 1;63:88-97 PMID:23220490 PubMed - indexed for MEDLINE

  19. Induction of apoptosis and growth arrest in human breast carcinoma cells by a snake (Walterinnesia aegyptia) venom combined with silica nanoparticles: crosstalk between Bcl2 and caspase 3.
    Al-Sadoon MK, Abdel-Maksoud MA, Rabah DM, Badr G
    Cell Physiol Biochem 2012;30(3):653-65 PMID:22854437 PubMed - indexed for MEDLINE

  20. Walterinnesia aegyptia venom combined with silica nanoparticles enhances the functioning of normal lymphocytes through PI3K/AKT, NF?B and ERK signaling.
    Badr G, Al-Sadoon MK, El-Toni AM, Daghestani M
    Lipids Health Dis 2012 Feb 15;11:27 PMID:22336518 PubMed - indexed for MEDLINE

  21. Purification and characterization of phosphodiesterase i from Walterinnesia aegyptia venom.
    Al-Saleh SS, Khan S
    Prep Biochem Biotechnol 2011;41(3):262-77 PMID:21660866 PubMed - indexed for MEDLINE

  22. Cloning, characterization and phylogenetic analyses of members of three major venom families from a single specimen of Walterinnesia aegyptia.
    Tsai HY, Wang YM, Tsai IH
    Toxicon 2008 Jun 1;51(7):1245-54 PMID:18405934 PubMed - indexed for MEDLINE

  23. Preparation of a novel antivenom against Atractaspis and Walterinnesia venoms.
    Ismail M, Al-Ahaidib MS, Abdoon N, Abd-Elsalam MA
    Toxicon 2007 Jan;49(1):8-18 PMID:17097125 PubMed - indexed for MEDLINE

  24. Walterinnesia aegyptia envenomation in a 22-year-old female: a case report.
    Lifshitz M, Maimon N, Livnat S
    Toxicon 2003 Mar;41(4):535-7 PMID:12657325 PubMed - indexed for MEDLINE

  25. Biochemical characterization of the soluble alkaline phosphatase isolated from the venomous snake W. aegyptia.
    Al-Saleh SS
    J Nat Toxins 2002 Dec;11(4):357-65 PMID:12503880 PubMed - indexed for MEDLINE

  26. Venomous snakes of Israel: ecology and snakebite.
    Kochva E
    Public Health Rev 1998;26(3):209-32 PMID:10444959 PubMed - indexed for MEDLINE

  27. Ultrastructural variations of rat myocardium due to Walterinnesia aegytia snake envenomation.
    al-Shammary FJ, al-Saleh SS, el-Shewemi SE
    J Electron Microsc (Tokyo) 1998;47(6):637-43 PMID:9972545 PubMed - indexed for MEDLINE

  28. Pharmacokinetics of 125I-labelled Walterinnesia aegyptia venom and its distribution of the venom and its toxin versus slow absorption and distribution of IGG, F(AB')2 and F(AB) of the antivenin.
    Ismail M, Abd-Elsalam MA, Al-Ahaidib MS
    Toxicon 1998 Jan;36(1):93-114 PMID:9604285 PubMed - indexed for MEDLINE

  29. Amino acid sequence of two neurotoxins from the venom of the Egyptian black snake (Walterinnesia aegyptia).
    Samejima Y, Aoki-Tomomatsu Y, Yanagisawa M, Mebs D
    Toxicon 1997 Feb;35(2):151-7 PMID:9080571 PubMed - indexed for MEDLINE

  30. Assessment of an ovine antivenom raised against venom from the desert black cobra (Walterinnesia aegyptia).
    al-Asmari AK, al-Abdulla IH, Crouch RG, Smith DC, Sjostrom L
    Toxicon 1997 Jan;35(1):141-5 PMID:9028017 PubMed - indexed for MEDLINE

  31. Kinetics of the inhibition of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom by local anesthetics: procaine and tetracaine.
    al-Jafari AA, Kamal MA, Duhaiman AS, Alhomida AS
    J Enzyme Inhib 1996 Oct;11(2):123-34 PMID:9204401 PubMed - indexed for MEDLINE

  32. The effect of the desert cobra (Walterinnesia aegyptia) crude venom and its protein fractions on the metabolic activity of cultured human fibroblasts.
    al-Saleh SS
    Cell Biol Toxicol 1996 Jun;12(3):127-34 PMID:8817058 PubMed - indexed for MEDLINE

  33. Purification and characterization of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom.
    Duhaiman AS, Alhomida AS, Rabbani N, Kamal MA, al-Jafari AA
    Biochimie 1996;78(1):46-50 PMID:8725010 PubMed - indexed for MEDLINE

  34. Purification and some properties of two phospholipases and a toxin from the venom of desert cobra (Walterinnesia aegyptia).
    Duhaiman AS, Rabbani N, al-Jafari A, Alhomida A
    Biochem Mol Biol Int 1995 Nov;37(5):1011-20 PMID:8624483 PubMed - indexed for MEDLINE

  35. Acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom: optimization and kinetics study.
    AlJafari AA, Kamal MA, Duhaiman AS, Alhomida AS
    Mol Cell Biochem 1995 Oct 4;151(1):21-6 PMID:8584009 PubMed - indexed for MEDLINE

  36. Isolation of phospholipase A from the venom of the desert black snake Walterinnesia aegyptia.
    Simon T, Bdolah A
    Toxicon 1980;18(3):369-73 PMID:7394826 PubMed - indexed for MEDLINE

  37. Chromatographic separation of the venom of Egyptian black snake (Walterinnesia aegyptia) and pharmacological characterization of its components.
    Lee CY, Chen YM, Mebs D
    Toxicon 1976;14(4):275-81 PMID:960110 PubMed - indexed for MEDLINE

  38. On ecology and the significance of semantic coloration in the nocturnal desert-elapid Walterinnesia aegyptia Lataste (Reptiles, Ophidia).
    Zinner H
    Oecologia 1971 Sep;7(3):267-275 PMID:28311252 PubMed

  39. Studies on the snake venoms of the near east:Walterinnesia aegyptia and Pseudocerastes fieldii.
    GITTER S, MOROZ-PERLMUTTER C, BOSS JH, LIVNI E, RECHNIC J, GOLDBLUM N, DE VRIES A
    Am J Trop Med Hyg 1962 Nov;11:861-8 PMID:13948250 PubMed - indexed for MEDLINE

  40. [Observations on the lyophilised venom of the Egyptian black snake Walterinnesia aegyptia].
    LATASTE F
    Harefuah 1958 Aug 1;55(3):54-7; English & French abstracts 57 PMID:13574640 PubMed - indexed for MEDLINE
For Research Purposes Only - Not for Human Use

Privacy Statement | Ordering Informations | www.latoxan.com | www.biotoxan.com
Natural Active Ingredients - Venoms - Toxins - Alkaloids - Plant Compounds - Ion Channel & Receptor Ligands
LATOXAN SAS - Z.A. les Auréats, 845 Avenue Pierre Brossolette - 26800 PORTES-lès-VALENCE - France - Phone +33 475 419 191 - Fax +33 475 419 199 - www.latoxan.com
Optimised for Mozilla FireFox & Google Chrome (not for IE) - Copyright © Latoxan 2010
Last update : 2024-12-22 04:07:06